Wealth Enhancement Advisory Services, LLC Harrow Health, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 4,189 shares of HROW stock, worth $170,659. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,189Holding current value
$170,659% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
224Shares Held
21.8MCall Options Held
998KPut Options Held
593K-
Opaleye Management Inc. Boston, MA3.91MShares$159 Million30.67% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$87.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$76.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.86MShares$75.6 Million9.42% of portfolio
-
State Street Corp Boston, MA794KShares$32.4 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.1B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...